Profile
Sector:
HealthcareCountry:
IsraelIPO:
14 September 1982Website:
http://www.taro.comNext earnings report:
26 July 2024Last dividends:
10 December 2018Next dividends:
N/APrice
after hours | Fri, 21 Jun 2024 22:41:06 GMTDividend
Analysts recommendations
Institutional Ownership
TARO Latest News
Combined entity is better positioned to compete in increasingly competitive generics industry MUMBAI, India and PRINCETON, N.J. , June 24, 2024 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715 (together with its subsidiaries and/or associated companies, "Sun Pharma")) today announced the successful completion of the merger of Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y.--(BUSINESS WIRE)--TARO PROVIDES RESULTS FOR YEAR ENDED MARCH 31, 2024.
MILWAUKEE , May 20, 2024 /PRNewswire/ -- Ademi LLP is investigating Taro (NYSE: TARO) for possible breaches of fiduciary duty and other violations of law in its transaction with its majority shareholder Sun. Click here to learn how to join the https://www.ademilaw.com/case/taro-pharmaceutical-industries-limited or call Guri Ademi toll-free at 866-264-3995.
Taro (TARO) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Taro (TARO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Taro received a $38/share offer from Sun Pharma last month. The deal represents a decent premium to the firm's market value at the time and a 12% premium to my estimate of fair value. Further insights reveal the deal could be valuable to Taro shareholders given all the contributing factors.
Taro saw rising revenue in the fourth quarter but falling net income. Sun Pharmaceutical already owns 78.5% of Taro's shares.
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the year ended March 31, 2023, after the close of market on Tuesday, May 23, 2023. The release will be accessible on Taro's website at www.taro.com. About Taro Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturi.
What type of business is Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1950 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
What sector is Taro Pharmaceutical Industries in?
Taro Pharmaceutical Industries is in the Healthcare sector
What industry is Taro Pharmaceutical Industries in?
Taro Pharmaceutical Industries is in the Drug Manufacturers - Specialty & Generic industry
What country is Taro Pharmaceutical Industries from?
Taro Pharmaceutical Industries is headquartered in Israel
When did Taro Pharmaceutical Industries go public?
Taro Pharmaceutical Industries initial public offering (IPO) was on 14 September 1982
What is Taro Pharmaceutical Industries website?
https://www.taro.com
Is Taro Pharmaceutical Industries in the S&P 500?
No, Taro Pharmaceutical Industries is not included in the S&P 500 index
Is Taro Pharmaceutical Industries in the NASDAQ 100?
No, Taro Pharmaceutical Industries is not included in the NASDAQ 100 index
Is Taro Pharmaceutical Industries in the Dow Jones?
No, Taro Pharmaceutical Industries is not included in the Dow Jones index
When does Taro Pharmaceutical Industries report earnings?
The next expected earnings date for Taro Pharmaceutical Industries is 26 July 2024